Identification of aryl hydrocarbon receptor binding targets in mouse hepatic tissue treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin

Toxicology and Applied Pharmacology

Volumn 257, Issue 1, 2011, Pages 38-47

  Lo, Raymond ^a   Celius, Trine ^a   Forgacs, Agnes L ^b,c   Dere, Edward ^b   MacPherson, Laura ^a   Harper, Patricia ^a,d   Zacharewski, Timothy ^b,c   Matthews, Jason ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Michigan State University   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; ChIP chip; Chromatin immunoprecipitation; Microarray

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CCAAT ENHANCER BINDING PROTEIN; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; GLUTAMATE ACETYLTRANSFERASE; GLUTAMATE CYSTEINE LIGASE; HYPOXIA INDUCIBLE FACTOR; MYC PROTEIN; NUCLEAR RESPIRATORY FACTOR 1; PROMYELOCYTIC LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; HEPATOMA CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER; MOUSE; NONHUMAN; PROTEIN MICROARRAY; PROTEIN MOTIF;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DIOXINS; FEMALE; GENE EXPRESSION REGULATION; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, ARYL HYDROCARBON; TRANSCRIPTION FACTORS;

EID: 81255144268     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.08.016     Document Type: Article

References (36)

1. Ahmed S., Valen E., Sandelin A., Matthews J. Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters. Toxicol. Sci. 2009, 111:254-266.
2. Birnbaum L.S. The mechanism of dioxin toxicity: relationship to risk assessment. Environ. Health Perspect. 1994, 102(Suppl. 9):157-167.
3. Boverhof D.R., Burgoon L.D., Tashiro C., Sharratt B., Chittim B., Harkema J.R., Mendrick D.L., Zacharewski T.R. Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol. Sci. 2006, 94:398-416.
4. Bunger M.K., Moran S.M., Glover E., Thomae T.L., Lahvis G.P., Lin B.C., Bradfield C.A. Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J. Biol. Chem. 2003, 278:17767-17774.
5. Bunger M.K., Glover E., Moran S.M., Walisser J.A., Lahvis G.P., Hsu E.L., Bradfield C.A. Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicol. Sci. 2008, 106:83-92.
6. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., Fox E.A., Silver P.A., Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
7. Choi S.S., Miller M.A., Harper P.A. In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin induces amphiregulin gene expression in the developing mouse ureter. Toxicol. Sci. 2006, 94:163-174.
8. De Abrew K.N., Kaminski N.E., Thomas R.S. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation. Toxicol. Sci. 2010, 118:454-469.
9. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003, 43:309-334.
10. Dere E., Boverhof D.R., Burgoon L.D., Zacharewski T.R. In vivo-in vitro toxicogenomic comparison of TCDD-elicited gene expression in Hepa1c1c7 mouse hepatoma cells and C57BL/6 hepatic tissue. BMC Genomics 2006, 7:80.
11. Dere E., Lo R., Celius T., Matthews J., Zacharewski T.R. Integration of genome-wide computation DRE search, AhR ChIP-chip and gene expression analyses of TCDD-elicited responses in the mouse liver. BMC Genomics 2011, 12:365.
12. Eeckhoute J., Lupien M., Meyer C.A., Verzi M.P., Shivdasani R.A., Liu X.S., Brown M. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res. 2009, 19:372-380.
13. Fernandez-Salguero P.M., Hilbert D.M., Rudikoff S., Ward J.M., Gonzalez F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 1996, 140:173-179.
14. Flaveny, C.A., Murray, I.A., Perdew, G.H., 2010. Differential gene regulation by the human and mouse aryl hydrocarbon receptor. Toxicol. Sci. 114, 217-225.
15. Ge N.L., Elferink C.J. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. J. Biol. Chem. 1998, 273:22708-22713.
16. Gouedard C., Barouki R., Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol. 2004, 24:5209-5222.
17. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 1995, 35:307-340.
18. Hankinson O. Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch. Biochem. Biophys. 2005, 433:379-386.
19. Harstad E.B., Guite C.A., Thomae T.L., Bradfield C.A. Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development. Mol. Pharmacol. 2006, 69:1534-1541.
20. Ji H., Wong W.H. TileMap: create chromosomal map of tiling array hybridizations. Bioinformatics 2005, 21:3629-3636.
21. Ji H., Jiang H., Ma W., Johnson D.S., Myers R.M., Wong W.H. An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat. Biotechnol. 2008, 26:1293-1300.
22. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
23. Lahvis G.P., Pyzalski R.W., Glover E., Pitot H.C., McElwee M.K., Bradfield C.A. The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol. Pharmacol. 2005, 67:714-720.
24. Lin X., Yang H., Zhou L., Guo Z. Nrf2-dependent induction of NQO1 in mouse aortic endothelial cells overexpressing catalase. Free Radic. Biol. Med. 2011, 51:97-106.
25. Marlowe J.L., Knudsen E.S., Schwemberger S., Puga A. The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. J. Biol. Chem. 2004, 279:29013-29022.
26. Moffat I.D., Boutros P.C., Chen H., Okey A.B., Pohjanvirta R. Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics 2010, 11:263.
27. Murray I.A., Morales J.L., Flaveny C.A., Dinatale B.C., Chiaro C., Gowdahalli K., Amin S., Perdew G.H. Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity. Mol. Pharmacol. 2010, 77:247-254.
28. Pansoy A., Ahmed S., Valen E., Sandelin A., Matthews J. 3-Methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters. Toxicol. Sci. 2010, 117:90-100.
29. Poland A., Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 1982, 22:517-554.
30. Pongratz I., Stromstedt P.E., Mason G.G., Poellinger L. Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment. J. Biol. Chem. 1991, 266:16813-16817.
31. Sartor M.A., Schnekenburger M., Marlowe J.L., Reichard J.F., Wang Y., Fan Y., Ma C., Karyala S., Halbleib D., Liu X., Medvedovic M., Puga A. Genomewide analysis of aryl hydrocarbon receptor binding targets reveals an extensive array of gene clusters that control morphogenetic and developmental programs. Environ. Health Perspect. 2009, 117:1139-1146.
32. Schmidt J.V., Su G.H., Reddy J.K., Simon M.C., Bradfield C.A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:6731-6736.
33. Schnekenburger M., Peng L., Puga A. HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation. Biochim. Biophys. Acta 2007, 1769:569-578.
34. Stender J.D., Kim K., Charn T.H., Komm B., Chang K.C., Kraus W.L., Benner C., Glass C.K., Katzenellenbogen B.S. Genome-wide analysis of estrogen receptor-{alpha} DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Mol. Cell. Biol. 2010, 30:3943-3955.
35. Tsuchiya Y., Nakajima M., Yokoi T. Critical enhancer region to which AhR/ARNT and Sp1 bind in the human CYP1B1 gene. J. Biochem. (Tokyo) 2003, 133:583-592.
36. Whitlock J.P. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 1999, 39:103-125.